
Amoéba S.A.
Update in progressALMIB.PA (Paris)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorBasic Materials
- IndustryAgricultural Inputs
Amoéba S.A. develops biological products and services to manage microbiological risk in water, health, and plant protection markets in France. The company uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky to treat water, surfaces, and chronic wounds, and also offers agricultural biocontrol products from lysed amoebae to combat phytopathogenic microorganisms. Founded in 2010, it is headquartered in Chassieu, France.
Company score
- Sentiment
- 0.42
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.32
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.19
- Governance
- 0.13
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.19
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.31
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!